Skip to main content
Fig. 6 | Clinical Epigenetics

Fig. 6

From: Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction

Fig. 6

TMEM240 DNA methylation and mRNA analysis from the TCGA dataset. Differentially methylated CpG sites in TMEM240 were identified in a 38 adjacent normal colorectal tissues, 38 matched colorectal carcinoma (CRC) tumors, and b 314 CRC tumors by an Illumina Methylation 450K array-based assay. c RNA sequencing data for TMEM240 in 41 adjacent normal colorectal tissues and 41 matched CRC tumors

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us